Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors

World Journal of Surgery

Volumn 17, Issue 4, 1993, Pages 511-519

  Arnold, Rudolf ^a,b   Neuhaus, Christian ^a,b   Benning, Ralph ^a,b   Schwerk, Wolf B ^a,b   Trautmann, Michael E ^a,b   Joseph, Klaus ^a,b   Bruns, Christian ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; GASTRIN; OCTREOTIDE; OMEPRAZOLE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; CANCER INHIBITION; CARCINOID SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTRINOMA; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TUMOR; HORMONE DETERMINATION; HUMAN; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PANCREAS TUMOR; STOMACH ACID SECRETION; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADENOMA, ISLET CELL; ADULT; AGED; CARCINOID TUMOR; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMAN; MALE; MIDDLE AGE; OCTREOTIDE; PANCREATIC NEOPLASMS;

EID: 0027296285     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/BF01655111     Document Type: Article

References (40)

1. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro
2. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
3. Somatostatin
4. Somatostatin
5. Somatostatin and the gastrointestinal tract
6. SMS 201-995: a very potent and selective octapeptide analog of somatostatin with prolonged action
7. Pharmacokinetics of SMS 201-995 in healthy subjects
8. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin
9. Potential role of somatostatin analogues in the treatment of cancer [editorial]
10. NIH conference: somatostatin and somatostatin analogue (SMS 201-955) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut
11. Therapeutic strategies in the management of endocrine GEP-tumors
12. Short-term administration of the somatostatin analogue SMS 201-995 in patients with carcinoid syndrome
13. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue
14. Use of somatostatin analogue in management of carcinoid syndrome
15. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera
16. Effects of long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera
17. Pancreatic cholera syndrome: effect of a synthetic somatostatin analogue on intestinal water and ion transport
18. Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue: symptomatic and peptide responses
19. Treatment of inoperable glucagonoma with long-acting somatostatin analogue SMS 201-995
20. Omeprazole in Zollinger-Ellison syndrome
21. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome
22. Use of long-acting somatostatin analogue SMS 201-995 in patients with pancreatic islet cell tumors
23. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients
24. Somatostatin and analogues in the treatment of cancer: a review
25. Long term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases
26. Effect of somatostatin analogue on peptide release and tumor growth in the Zollinger-Ellison syndrome
27. Ultrastrukturelle Diagnostik neuroendokriner Tumoren an Feinnadelpunktaten
28. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome
29. Identification and characterization of somatostatin receptors in neonatal rat long bones
30. Receptor scintigraphy with radioiodinated somatostatin analogue: radio labeling, purification, biologic activity, and in vivo application in animals
31. Growth factor receptor monoclonal antibodies and cancer immunotherapy [editorial]
32. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors
33. Carcinoid tumors have a high density of somatostatin receptors that may be assessed by percutaneous needle biopsy
34. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis
35. Treatment of metastasing GRF-producing tumor with a long-acting somatostatin analogue
36. Can inhibition of hormone secretion be associated with endocrine tumor shrinkage?
37. Regression of metastatic VIPoma with somatostatin analogue SMS 201-995
38. Regression of liver metastases in patient with gastrin-secreting tumor treated with SMS 201-995
39. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue
40. Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995